Concentrix (CNXC) Projected to Post Earnings on Thursday

Concentrix (NASDAQ:CNXC - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, June 26th. Analysts expect the company to announce earnings of $2.76 per share and revenue of $2.38 billion for the quarter.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported $2.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.58 by $0.21. Concentrix had a net margin of 2.81% and a return on equity of 16.73%. The business had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.37 billion. During the same quarter in the prior year, the business posted $2.57 EPS. The company's revenue for the quarter was down 1.3% on a year-over-year basis.

Concentrix Stock Performance

NASDAQ:CNXC traded down $3.01 during trading hours on Friday, reaching $50.15. 1,464,090 shares of the stock were exchanged, compared to its average volume of 724,048. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 1.22. The firm has a 50 day simple moving average of $53.32 and a 200-day simple moving average of $49.24. Concentrix has a 52 week low of $36.28 and a 52 week high of $77.00. The stock has a market capitalization of $3.20 billion, a P/E ratio of 12.57, a P/E/G ratio of 0.65 and a beta of 0.56.

Concentrix Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 6th. Shareholders of record on Friday, April 25th were issued a dividend of $0.3328 per share. This represents a $1.33 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date of this dividend was Friday, April 25th. Concentrix's dividend payout ratio is presently 33.33%.

Insider Activity

In related news, EVP Cormac J. Twomey sold 500 shares of the company's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $55.31, for a total transaction of $27,655.00. Following the transaction, the executive vice president now directly owns 39,130 shares of the company's stock, valued at approximately $2,164,280.30. The trade was a 1.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Olivier Duha sold 29,444 shares of the company's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $48.52, for a total value of $1,428,622.88. Following the transaction, the director now directly owns 1,155,862 shares in the company, valued at $56,082,424.24. The trade was a 2.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,944 shares of company stock worth $1,510,158 over the last 90 days. 3.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Concentrix

A number of large investors have recently made changes to their positions in CNXC. Geneos Wealth Management Inc. increased its stake in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after buying an additional 522 shares during the period. Focus Partners Wealth acquired a new position in Concentrix in the 1st quarter valued at approximately $781,000. Royal Bank of Canada increased its stake in Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock valued at $2,643,000 after buying an additional 4,133 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock worth $8,152,000 after acquiring an additional 21,746 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock worth $23,552,000 after acquiring an additional 181,546 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on CNXC. Bank of America raised their price objective on Concentrix from $59.00 to $65.00 and gave the stock a "neutral" rating in a research note on Monday, June 9th. Barrington Research cut their target price on shares of Concentrix from $70.00 to $54.00 and set an "outperform" rating on the stock in a report on Monday, March 24th. Finally, Wall Street Zen cut Concentrix from a "buy" rating to a "hold" rating in a research note on Saturday. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $67.25.

Concentrix Company Profile

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.